Adlai Nortye Group Ltd. SEC filings ANL

Adlai Nortye Group Ltd. has 114 filings in SEC EDGAR's recent list, going back to Dec 21, 2022. Its latest annual report, Form 20-F, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 28, 2026. The company's fiscal year ends on December 31.

Form Description Filed Period
S-8 POS Registration statement Sep 11, 2026 —
S-8 POS Registration statement Sep 11, 2026 —
POS AM Post-effective amendment no. 1 to form f-3 Sep 11, 2026 —
424B7 Prospectus supplement Jul 20, 2026 —
F-3/A Amendment no. 2 to form f-3 Apr 24, 2026 —
F-3/A Amendment no. 1 to form f-3 Apr 23, 2026 —
F-3 Shelf registration (foreign issuer) Mar 10, 2026 —
S-8 Employee stock plan registration Sep 16, 2025 —
S-8 Employee stock plan registration May 13, 2024 —
424B4 Prospectus Sep 29, 2023 —
F-1/A Filing Sep 27, 2023 —
F-1/A Filing Sep 12, 2023 —
F-1/A Filing Aug 14, 2023 —
F-1/A Filing Aug 10, 2023 —
F-1 Registration statement (foreign issuer) Jul 27, 2023 —

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ANL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Singapore
Headquarters
Singapore
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1944552
Former names
Adlai Nortye Ltd. (until Aug 19, 2026)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.